Trials
Search / Trial NCT05661318

AHC Ballana Heart Study

Launched by MAGDI YACOUB HEART FOUNDATION · Dec 14, 2022

Trial Information

Current as of February 05, 2025

Recruiting

Keywords

Genetics Cardiovascular Risks

ClinConnect Summary

The AHC Ballana Heart Study is researching how heart diseases develop and progress in people who might have a genetic risk for these conditions. The study aims to understand the number of people affected by cardiovascular diseases, what factors contribute to them, and how this information can help improve heart health in the future. This research will be important for planning future studies and health policies.

If you live in Ballana and are between the ages of 65 and 74, you may be eligible to participate in this study. To join, you need to have a valid National ID card and provide written consent to take part. If you decide to participate, you'll help contribute to important heart health research that could benefit your community. It's a chance to be part of something that could lead to better understanding and treatment of heart diseases in the future.

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • Residents of Ballana from the 1,200 randomly selected households
  • Participants must have a valid National ID card
  • Written informed consent
  • Exclusion criteria:
  • • Residents who are younger than 18 years

Trial Officials

Magdi H Yacoub, FRS OM

Principal Investigator

Imperial College London, and Magdi Yacoub Heart Foundation

About Magdi Yacoub Heart Foundation

The Magdi Yacoub Heart Foundation is a prominent non-profit organization dedicated to advancing cardiovascular health and research. Founded by renowned cardiac surgeon Sir Magdi Yacoub, the foundation focuses on improving the quality of life for patients with heart diseases through innovative clinical trials, education, and community outreach. By fostering collaboration among healthcare professionals, researchers, and patients, the foundation aims to drive breakthroughs in cardiac treatment and enhance the delivery of cardiac care, ultimately contributing to the reduction of heart disease prevalence globally.

Locations

Aswan, , Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials